共 182 条
[1]
DeWane ME(2020)Dermatomyositis: Clinical features and pathogenesis J Am Acad Dermatol 82 267-281
[2]
Waldman R(2021)Dermatomyositis with anti-MDA5 antibodies: bioclinical features pathogenesis and emerging therapies Front Immunol 12 773352-146
[3]
Lu J(2015)Biomarkers and autoantibodies of interstitial lung disease with idiopathic inflammatory myopathies Clin Med Insights Circ Respir Pulm Med 9 141-1719
[4]
Nombel A(2010)Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis Rheumatology 49 1713-140
[5]
Fabien N(2018)Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients Mod Rheumatol 28 133-92
[6]
Coutant F(2020)Group EtWS: 239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018 Neuromuscul Disord 30 70-1654
[7]
Yoshifuji H(2007)Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study Clin Rheumatol 26 1647-1556
[8]
Gono T(2002)Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors Am J Respir Crit Care Med 165 1551-304
[9]
Kawaguchi Y(2021)Interstitial lung disease in Anti-MDA5 positive dermatomyositis Clin Rev Allergy Immunol 60 293-631
[10]
Satoh T(2019)Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis Eur J Clin Investig 31 626-886